5:48 PM
 | 
Oct 22, 2013
 |  BC Extra  |  Financial News

Ziopharm planning $50 million follow-on

Ziopharm Oncology Inc. (NASDAQ:ZIOP) late Tuesday proposed to raise $50 million in a follow-on underwritten by JPMorgan. Ziopharm said partner Intrexon Corp. (NYSE:XON) may purchase up...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >